Jason McCarthy Score: 23
Analyst at
Maxim Group
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+326.8%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
53%
8 W / 7 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
40%
4 W / 6 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 10 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 10 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
53%
8 W / 7 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
53%
8 W / 7 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 |
Zevra Therapeutics Inc
ZVRA
|
BUY |
$35.00
Est. +156%
|
$13.67 | $15.02 |
Pending
|
$9.08
-33.6%
|
| May 15, 2026 |
Compass Pathways Plc - ADR
CMPS
|
BUY |
$20.00
Est. +92%
|
$10.40 | $15.86 |
Pending
|
$9.01
-13.4%
|
| Dec 12, 2025 |
Rezolute Inc
RZLT
|
BUY |
$4.00
Est. +153%
|
$1.58 | $5.42 |
Target Met
|
$3.66
+131.3%
|
| May 20, 2025 |
Bionano Genomics Inc
BNGO
|
BUY |
$8.00
Est. +112%
|
$3.77 | $5.50 |
Miss
|
$1.00
-73.5%
|
| Sep 25, 2024 |
Capricor Therapeutics Inc
CAPR
|
BUY |
$25.00
Est. +175%
|
$9.10 | $23.40 |
Miss
|
$9.53
+4.7%
|
| Sep 24, 2024 |
Zevra Therapeutics Inc
ZVRA
|
BUY |
$25.00
Est. +230%
|
$7.58 | $13.16 |
Miss
|
$9.08
+19.8%
|
| Sep 24, 2024 |
Mesoblast Ltd - ADR
MESO
|
BUY |
$12.00
Est. +78%
|
$6.74 | $22.00 |
Target Met
|
$13.27
+96.9%
|
| Sep 10, 2024 |
Cns Pharmaceuticals Inc
CNSP
|
BUY |
$0.50
Est. +233%
|
$0.15 | $222.00 |
Target Met
|
$2.91
+1840.0%
|
| Aug 06, 2024 |
Actinium Pharmaceuticals Inc
ATNM
|
BUY |
$5.00
Est. +102%
|
$2.48 | $3.45 |
Miss
|
$1.64
-33.9%
|
| Jun 07, 2024 |
Avenue Therapeutics Inc
ATXI
|
BUY |
$12.00
Est. +254%
|
$3.39 | $3.93 |
Miss
|
$0.39
-88.5%
|
| Apr 09, 2024 |
Lipella Pharmaceuticals Inc
LIPO
|
BUY |
$2.00
Est. +186%
|
$0.70 | $12.00 |
Target Met
|
$0.00
-99.9%
|
| Apr 03, 2024 |
ATAI Life Sciences N.V.
ATAI
|
BUY |
$6.00
Est. +221%
|
$1.87 | $2.57 |
Miss
|
$7.35
+293.0%
|
| Jun 14, 2022 |
CF Industries Holdings Inc
CF
|
BUY |
$325.00
Est. +942%
|
$31.20 | - | - |
$125.16
+301.2%
|
| Feb 03, 2022 |
Gilead Sciences, Inc.
GILD
|
BUY |
$84.00
Est. +30%
|
$64.57 | - | - |
$168.08
+160.3%
|
| Aug 05, 2021 |
Karuna Therapeutics Inc
KRTX
|
BUY |
$150.00
Est. +27%
|
$117.81 | - | - |
$329.83
+180.0%
|
Zevra Therapeutics Inc
ZVRA
Jun 10, 2026
Signal & Target
BUY
$35.00
Start Price
$13.67
Best Price (1Y)
$15.02
Current Price
$9.08
Return
-33.6%
Compass Pathways Plc - ADR
CMPS
May 15, 2026
Signal & Target
BUY
$20.00
Start Price
$10.40
Best Price (1Y)
$15.86
Current Price
$9.01
Return
-13.4%
Rezolute Inc
RZLT
Dec 12, 2025
Signal & Target
BUY
$4.00
Start Price
$1.58
Best Price (1Y)
$5.42
Current Price
$3.66
Return
+131.3%
Bionano Genomics Inc
BNGO
May 20, 2025
Signal & Target
BUY
$8.00
Start Price
$3.77
Best Price (1Y)
$5.50
Current Price
$1.00
Return
-73.5%
Capricor Therapeutics Inc
CAPR
Sep 25, 2024
Signal & Target
BUY
$25.00
Start Price
$9.10
Best Price (1Y)
$23.40
Current Price
$9.53
Return
+4.7%
Zevra Therapeutics Inc
ZVRA
Sep 24, 2024
Signal & Target
BUY
$25.00
Start Price
$7.58
Best Price (1Y)
$13.16
Current Price
$9.08
Return
+19.8%
Mesoblast Ltd - ADR
MESO
Sep 24, 2024
Signal & Target
BUY
$12.00
Start Price
$6.74
Best Price (1Y)
$22.00
Current Price
$13.27
Return
+96.9%
Cns Pharmaceuticals Inc
CNSP
Sep 10, 2024
Signal & Target
BUY
$0.50
Start Price
$0.15
Best Price (1Y)
$222.00
Current Price
$2.91
Return
+1840.0%
Actinium Pharmaceuticals Inc
ATNM
Aug 06, 2024
Signal & Target
BUY
$5.00
Start Price
$2.48
Best Price (1Y)
$3.45
Current Price
$1.64
Return
-33.9%
Avenue Therapeutics Inc
ATXI
Jun 07, 2024
Signal & Target
BUY
$12.00
Start Price
$3.39
Best Price (1Y)
$3.93
Current Price
$0.39
Return
-88.5%
Lipella Pharmaceuticals Inc
LIPO
Apr 09, 2024
Signal & Target
BUY
$2.00
Start Price
$0.70
Best Price (1Y)
$12.00
Current Price
$0.00
Return
-99.9%
ATAI Life Sciences N.V.
ATAI
Apr 03, 2024
Signal & Target
BUY
$6.00
Start Price
$1.87
Best Price (1Y)
$2.57
Current Price
$7.35
Return
+293.0%
CF Industries Holdings Inc
CF
Jun 14, 2022
Signal & Target
BUY
$325.00
Start Price
$31.20
Best Price (1Y)
-
Current Price
$125.16
Return
+301.2%
Gilead Sciences, Inc.
GILD
Feb 03, 2022
Signal & Target
BUY
$84.00
Start Price
$64.57
Best Price (1Y)
-
Current Price
$168.08
Return
+160.3%
Karuna Therapeutics Inc
KRTX
Aug 05, 2021
Signal & Target
BUY
$150.00
Start Price
$117.81
Best Price (1Y)
-
Current Price
$329.83
Return
+180.0%